Anticoagulant Activity of Sulfated Ulvan Isolated from the Green Macroalga Ulva rigida

(1) Background: Brown and red algal sulfated polysaccharides have been widely described as anticoagulant agents. However, data on green algae, especially on the genus, are limited. This study aimed at isolating ulvan from the green macroalga using an acid- and solvent-free procedure, and investigati...

Full description

Saved in:
Bibliographic Details
Published inMarine drugs Vol. 17; no. 5; p. 291
Main Authors Adrien, Amandine, Bonnet, Antoine, Dufour, Delphine, Baudouin, Stanislas, Maugard, Thierry, Bridiau, Nicolas
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 14.05.2019
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:(1) Background: Brown and red algal sulfated polysaccharides have been widely described as anticoagulant agents. However, data on green algae, especially on the genus, are limited. This study aimed at isolating ulvan from the green macroalga using an acid- and solvent-free procedure, and investigating the effect of sulfate content on the anticoagulant activity of this polysaccharide. (2) Methods: The obtained ulvan fraction was chemically sulfated, leading to a doubling of the polysaccharide sulfate content in a second ulvan fraction. The potential anticoagulant activity of both ulvan fractions was then assessed using different assays, targeting the intrinsic and/or common (activated partial thromboplastin time), extrinsic (prothrombin time), and common (thrombin time) pathways, and the specific antithrombin-dependent pathway (anti-Xa and anti-IIa), of the coagulation cascade. Furthermore, their anticoagulant properties were compared to those of commercial anticoagulants: heparin and Lovenox . (3) Results: The anticoagulant activity of the chemically-sulfated ulvan fraction was stronger than that of Lovenox against both the intrinsic and extrinsic coagulation pathways. (4) Conclusion: The chemically-sulfated ulvan fraction could be a very interesting alternative to heparins, with different targets and a high anticoagulant activity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMCID: PMC6562387
ISSN:1660-3397
1660-3397
DOI:10.3390/md17050291